ADACC Network

07/22/2026

⭐ We’re excited to spotlight ADACC Steering Committee member Jeffrey Dage, PhD, whose work has helped transform the landscape of Alzheimer’s disease research. ⭐

🧪 Dr. Dage’s development of reliable blood-based biomarkers, including pTau181 and pTau217, has accelerated clinical trials, expanded access to pathology measurement, and opened the door to true precision medicine in Alzheimer’s disease and related dementias.

05/13/2026

⭐ Member Spotlight | May ⭐

The ADACC Network is delighted to highlight Executive Committee Member, Dr. Thomas KariKari, as our May Spotlight honoree.

05/01/2026

🎥 Conference recordings are now available on YouTube!

If you missed it, or would like to revisit the speaker sections, we have uploaded recordings from the ADACC Network's 3rd Annual Conference, held in partnership with the GEAR Network 2.0, to our YouTube channel.

🔗 You can check out the full conference agenda and speaker details here:https://www.adaccnetwork.net/_files/ugd/eea487_4c5f7a8718aa46bb9914a97fe6558b54.pdf

🔗 For those interested, you can find the conference recordings here: https://www.youtube.com/playlist?list=PLTRUQpzGIJy9MjX8EpdU8knchzSyBXbz2

03/05/2026

⭐ Member Spotlight | March ⭐

The ADACC Network is delighted to highlight Executive Committee Member, Dr. Jeff Williamson, as our March Spotlight honoree.

Dr. Jeff Williamson is an Academic Faculty Physician and Section Chief at the Wake Forest University School of Medicine. He is an internationally known geriatrician and clinical trialist whose research focuses on the relationships between chronic diseases-such as hypertension and diabetes- and the preservation of brain health and physical function in aging adults. As Director of the Wake Forest Center for Healthcare Innovation and co-leader of the Alzheimer’s Disease Research Center, he has led large-scale NIH-funded studies involving tens of thousands of older adults, advancing understanding of cognitive decline prevention and aging-related loss of independence. His work has significantly shaped modern approaches to Alzheimer’s prevention, mobility, and frailty research, and the inclusion of older adults in clinical trials, reinforcing his role as national leader in aging science.

02/26/2026

🧠 We are pleased to highlight Catherine Scipion, MD, MPH as first author on a newly released article from the Ethical Considerations Working Group, led by Jalayne Arias, J.D., M.A. 🧠

This work represents a collaborative effort from members of the working group, Michelle Mielke, Allyson Rosen, with the addition of co-author Suzanne Schindler.

We’re proud of the team’s continued commitment to advancing ethical guidance in the Alzheimer's disease and biomarkers research community.

All ADACC Network working groups are open to new members.
To learn more or get involved, visit the ADACC Networks website.
https://www.adaccnetwork.net/working-groups
https://www.nature.com/articles/s44400-026-00060-4

This paper proposes a conceptual ethical framework to guide decision-making around blood-based biomarker (BBM) testing for Alzheimer’s disease in primary care, where patients often present with cognitive impairment and multiple chronic conditions. Grounded in current evidence and ethical principle...

02/02/2026

⭐️ Member Spotlight | February ⭐️

The ADACC Network is proud to highlight Executive Committee Member, Dr. Nicole Fowler , as our February Spotlight honoree.

We sincerely value Dr. Fowlers’ leadership, depth of expertise, and continued impact in advancing the mission of ADACC.

Additonally, we are happy to share a recently published article by our committee members—“Blood-Based Biomarkers for Alzheimer Disease: Preventing Unintended Consequences”—authored by Drs. Whitson, Fowler, and Mielke.

01/28/2026

📣 Deadline Extended for ADACC Network Pilot Proposals
Due to the recent winter storm, the ADACC Network is extending the submission deadline for pilot proposals to Monday, February 2nd, by 8:00 PM EST.

Please note that the application form still reflects the original deadline; however, the new deadline above will be honored.

🔗 More Information:
https://www.adaccnetwork.net/funding-opportunites
🔗 2026 Pilot Application Form:
https://redcap.school.wakehealth.edu/surveys/?s=FHCECTW9TFC3PLNW

We hope everyone stayed safe over the weekend!
If you have any questions, please reach out to [email protected].

01/14/2026

⭐️ Member Spotlight | January ⭐️

The ADACC Network is proud to highlight Executive Committee Member, Dr. Michelle Mielke, as our January Spotlight honoree.

We are grateful for Dr. Mielke’s leadership, expertise, and continued contributions to advancing the mission of ADACC.

12/05/2025

The ADACC Network is still accepting proposals for pilot projects focused on blood-based biomarker testing for Alzheimer’s disease in older adults with multiple chronic conditions!

🔬 The ADACC Pilot Committee will select up to three proposals for funding.
📅 Deadline to apply: Wednesday, January 28, 2026, by 8:00 PM EST
📖 Learn more: https://www.adaccnetwork.net/funding-opportunites
🔗 Apply here: https://redcap.school.wakehealth.edu/surveys/?s=FHCECTW9TFC3PLNW

We encourage you to share this opportunity with colleagues or collaborators who may be interested.

📩 For questions or assistance, contact us at [email protected]

hashtag hashtag hashtag hashtag hashtag

11/21/2025

Two members of the ADACC Network, Drs. Ambar Kulshreshtha and Nicole Fowler, collaborated with colleagues on a recent study of 324 older adults in primary care. The study found that over 50% had mild cognitive impairment (MCI) and 8% had Alzheimer’s disease or related dementias (ADRD)—without a formal diagnosis. These individuals also carried a heavier burden of chronic conditions and medications, including higher use of anticholinergics, which can worsen cognition.

🔍 Cognitive decline often goes undetected in older adults with multiple chronic conditions—highlighting the urgent need for integrated screening and safer prescribing in primary care.

📚 Read more: